MOBILE-HEALTH NETWORK SOLUTI (MNDR)
KYG622641093 - Common Stock
Taking everything into account, MNDR scores 3 out of 10 in our fundamental rating. MNDR was compared to 110 industry peers in the Health Care Providers & Services industry. The financial health of MNDR is average, but there are quite some concerns on its profitability. MNDR shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
In the past year MNDR has reported negative net income.
In the past year MNDR has reported a negative cash flow from operations.
1.2 Ratios
The Return On Assets of MNDR (-214.63%) is worse than 97.27% of its industry peers.
The Return On Equity of MNDR (-412.24%) is worse than 84.55% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -214.63% | ||
| ROE | -412.24% | ||
| ROIC | N/A |
ROA(3y)-96.24%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
MNDR has a Gross Margin of 18.18%. This is in the lower half of the industry: MNDR underperforms 65.45% of its industry peers.
MNDR's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for MNDR so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 18.18% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.09%
GM growth 5YN/A
2. Health
2.1 Basic Checks
MNDR does not have a ROIC to compare to the WACC, probably because it is not profitable.
MNDR has more shares outstanding than it did 1 year ago.
MNDR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
Based on the Altman-Z score of -6.60, we must say that MNDR is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -6.60, MNDR is not doing good in the industry: 89.09% of the companies in the same industry are doing better.
There is no outstanding debt for MNDR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -6.6 |
ROIC/WACCN/A
WACC8.82%
2.3 Liquidity
MNDR has a Current Ratio of 2.31. This indicates that MNDR is financially healthy and has no problem in meeting its short term obligations.
MNDR has a better Current ratio (2.31) than 79.09% of its industry peers.
MNDR has a Quick Ratio of 2.26. This indicates that MNDR is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of MNDR (2.26) is better than 79.09% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.31 | ||
| Quick Ratio | 2.26 |
3. Growth
3.1 Past
The earnings per share for MNDR have decreased strongly by -356.07% in the last year.
MNDR shows a strong growth in Revenue. In the last year, the Revenue has grown by 89.75%.
The Revenue has been growing by 75.52% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-356.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-493.67%
Revenue 1Y (TTM)89.75%
Revenue growth 3Y75.52%
Revenue growth 5YN/A
Sales Q2Q%77.38%
3.2 Future
The Earnings Per Share is expected to grow by 46.76% on average over the next years. This is a very strong growth
Based on estimates for the next years, MNDR will show a very strong growth in Revenue. The Revenue will grow by 78.77% on average per year.
EPS Next Y69.23%
EPS Next 2Y46.76%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year81.13%
Revenue Next 2Y78.77%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for MNDR. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MNDR. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as MNDR's earnings are expected to grow with 46.76% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y46.76%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for MNDR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
MOBILE-HEALTH NETWORK SOLUTI
NASDAQ:MNDR (12/2/2024, 8:00:01 PM)
Premarket: 0.3125 +0.01 (+1.79%)0.307
+0.02 (+7.79%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap10.59M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -214.63% | ||
| ROE | -412.24% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 18.18% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover2.59
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.31 | ||
| Quick Ratio | 2.26 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-356.07%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y69.23%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)89.75%
Revenue growth 3Y75.52%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y